MedTrace Logo

Reducing Anxiety and Stress in Primary Care Patients

NCT03794089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-07-27

Study results available
· View outcomes & findings →

Summary

Anxiety is common among primary care patients, but is undertreated. The purpose of this study is to evaluate whether a brief anxiety treatment designed for VA primary care is more effective at reducing anxiety symptoms in Veterans compared to usual care. The investigators will also examine whether Veterans like the brief treatment and whether the treatment can be feasibly delivered in primary care. Forty-eight adult Veteran primary care patients from the Syracuse VAMC who are experiencing anxiety symptoms will be recruited and randomly assigned to receive the brief anxiety treatment or usual care. The brief treatment consists of up to six 30-minute sessions with a cognitive-behavioral skills focus. The investigators will compare anxiety symptom severity between the two groups at baseline and at post-assessment 16 weeks later.

Conditions

Interventions

BEHAVIORAL

Brief anxiety intervention

Modular anxiety intervention, tailored for Veterans, with emphasis on adaptive coping skills

BEHAVIORAL

Usual PC-MHI care

Anxiety treatment with mental health provider in local primary care clinic

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Robyn L. Shepardson, PhD · Syracuse VA Medical Center, Syracuse, NY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-03-17
Completion
2021-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03794089 on ClinicalTrials.gov